Results 71 to 80 of about 4,705 (157)
Background: Snakebites have been recognised as a neglected tropical disease by the World Health Organization and remain a potentially preventable cause of morbidity around the world, particularly in Africa.
Matamba Jean Benoit Kabeya +2 more
doaj +1 more source
Antivenom Administration After Rattlesnake Envenoming in Arizona Does Not Directly Diminish Pain
The onset, progression, and severity of pain following rattlesnake envenomation are highly variable between patients. Pain can be severe and persistent, seemingly refractory to opioid analgesics.
Vance G. Nielsen +6 more
doaj +1 more source
Background: The parenteral administration of antivenoms is the mainstay in snakebite envenoming therapy. The standardized protocol does not exist, but it is agreed that the intravenous (i.v.) route is more effective than the others, especially the ...
Erika Gamulin +9 more
doaj +1 more source
Background: Joint diseases such as rheumatoid arthritis are among common and debilitating disease of the time. Current treatments are limited due to lack of efficacy and high incidence of side effects.
M Ahmadi +3 more
doaj
Because it primarily affects the poor in undeveloped parts of the world where medical care is often inadequate and insufficient, envenomation is considered a neglected public health issue, despite the existence of antivenom therapy for more than a century. This article provides an overview of the epidemiological situation for important venomous animals,
Lovreček, Dijana, Tomić, Siniša
openaire +3 more sources
Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the "Big Five" Snake Species in Kenya. [PDF]
Musabyimana V +15 more
europepmc +1 more source
Role of Serum IL-33 in <i>Bothrops</i> Snakebite Victims: Linking Inflammation and Endothelial Dysfunction. [PDF]
Lopes NC +13 more
europepmc +1 more source
Variation in the quantity of venom produced by snakes at the national center for production and strategic public health goods and the need to update antivenom estimations. [PDF]
Marcas G +3 more
europepmc +1 more source

